More than 860 infected health workers in Aragon: the faces behind the figures
11 May 2020
Spain, fourth country in the world and first in Europe in clinical trials of treatments against coronavirus
12 May 2020
The firm is already working to increase production and will begin manufacturing the vaccine this year.
The American giant Johnson & Johnson has announced that it plans to manufacture 1.000 billion coronavirus vaccines next year, as explained by the company's chief scientist, Paul Stoffels.
"We are going to start clinical trials in September and we hope to have the data by the end of the year (...). We are working to have 1.000 billion vaccines for next year," Stoffels explained in statements to ABC television. .
Johnson & Johnson is already working to increase production and will begin manufacturing the vaccine this year, Stoffels said. "Clinical trials are necessary to show that it is effective and that will take time," he indicated.
"We are going to have a vaccine available this year, but it will be up to the authorities to decide whether it can be used before the efficacy data are available," he stressed.
